Eyevensys lève 30M$

(08/01/2020) Paris, France, and Fort Worth, Texas, United States – Eyevensys, a privately held clinical-stage biotechnology company developing non-viral gene therapies for retinal and other [...]

page 1 sur 4
Nous contacter

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt